Appointments: IFPMA, Myokardia, ABPI, Mission Therapeutics, F2G, Arquer Diagnostics and Innovative Medicines Canada
Executive Summary
This week's roundup includes top level updates from AstraZeneca and executive appointments by Myokardia, Asceneuron and Arquer Diagnostics.